Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1990-09-18
1991-07-23
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
514533, 514913, A61K 31215, A61K 31235
Patent
active
050344137
ABSTRACT:
Certain 9,11-diacyl prostaglandins and their use for lowering intraocular pressure are disclosed herein.
REFERENCES:
patent: 4060540 (1977-11-01), Bernady et al.
patent: 4599353 (1986-07-01), Bito
Starr, Exp. Eye Res. 11, 170-177 (1971).
Zajacz et al., The Eye: Reproduction, Obstetrics and Gynecology 4, 316 (1976).
Keun Kim Investigative Ophthalmology 14, 36 (1975).
Camras et al., Invest. Ophthalmol. Visual Sci. 16, 1125 (1977).
Woodward et al., Invest. Ophthalmol. Visual Sc. 30, 1838 (1989).
Nilsson et al., Exp. Eye Res. 48, 707 (1989).
Bito, Arch. Ophthalmol. 105, 1036 (1987).
Siebold et al., Prodrug 5, 3 (1989).
Chan Ming F.
Gluchowski Charles
Woodward David F.
Allergan Inc.
Baran Robert J.
Fay Zohreh A.
Voet Martin A.
Waddell Frederick E.
LandOfFree
Intraocular pressure reducing 9,11-diacyl prostaglandins does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Intraocular pressure reducing 9,11-diacyl prostaglandins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Intraocular pressure reducing 9,11-diacyl prostaglandins will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-432605